Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995)

The American Journal of Medicine

Volumn 81, Issue 6 SUPPL. 2, 1986, Pages 56-64

  Ellison, E Christopher ^a   Gower, William R ^a   Elkhammas, Elmahdi ^a   Woltering, Eugene A ^a   Sparks, Joann ^a   O'dorisio, Thomas M ^a   Fabri, Peter J ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BUCLADESINE; DRUG DERIVATIVE; GASTRIN; OCTREOTIDE; SECRETIN; SOMATOSTATIN;

ADULT; ARTICLE; HUMAN; IN VITRO STUDY; MALE; ZOLLINGER ELLISON SYNDROME;

ADULT; ANTINEOPLASTIC AGENTS; BUCLADESINE; GASTRINS; HUMAN; IN VITRO; MALE; OCTREOTIDE; SECRETIN; SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ZOLLINGER-ELLISON SYNDROME;

EID: 0023055369     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(86)90585-1     Document Type: Article

References (23)

1. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
2. Inhibition of gastrin and gastric acid secretion by growth hormone release inhibiting hormone
3. Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes
4. Somatostatin inhibits fluid secretion in rat jejunum
5. Somatostatin stimulates sodium and chloride absorption in the rabbit ileum
6. The effect of somatostatin analogs on secretion of growth pancreatic and gastrointestinal hormone in man
7. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man
8. Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography
9. SMS 201-995: a very potent and selective octapeptide of somatostatin with prolonged actions
10. Efficacy of long-acting somatostatin analog (SMS 201-995) in the ulcerogenic syndrome (abstr)
11. Long-acting somatostatin analog for patients with gastrinoma syndrome (abstr)
12. Effect of long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera
13. Use of somatostatin and somatostatin analogs in a patient with glucagonoma
14. Somatostatin, gastrointestinal peptides, and the carcinoid syndrome
15. Effect of calcium on vasoactive intestinal peptide release from an islet cell tumor associated with the Verner-Morrison syndrome
16. Somatostatin is an agonist and noncompetitive antagonist of gastrin in oxynitic cell function
17. Selective effects of somatostatin-14, -25, -28 on in vitro insulin and glucagon secretion
18. Characterization of functional receptors for somatostatin in rat pituitary cells in culture
19. Postreceptor inhibitor of antral gastrin release by somatostatin
20. Mechanisms of somatostatin action in pituitary cells
21. Regulation and actions of gastrointestinal somatostatin